In work supported by the ALS association, CTRND researchers have had a paper published in Acta Neuropathologica in which they shed light on a potential mechanism for the spread of ALS through the Central Nervous System. This provides a potential target for the development of a gene therapy for the treatment of ALS.
CTRND Post-doctoral fellow Jacob Ayers, Ph.D. conducted the study under the direction of David Borchelt, Ph.D., a CTRND faculty member.
Click HERE to read the entire ALS Association press release.
Click HERE to read the abstract on PubMed